References
- Sørensen MN, Sørensen IV, Würtz SØ, Schrohl A-S, Dowell B, Davis G, et al. Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment. Scand J Gastroenterol 2008; 43: 774–86
- Venerito M, Treiber G, Wex T, Kuester D, Roessner A, Mönkemüller K, et al. Short-term/low-dose aspirin-induced duodenal erosions are not dependent on the Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels. Scand J Gastroenterol 2008; 43: 801–9
- Blonski W, Kundu R, Furth EF, Lewis J, Aberra F, Lichtenstein GR. High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis. Scand J Gastroenterol 2008; 43: 817–20
- Haapamäki J, Turunen U, Roine RP, Färkkilä M, Arkkila PET. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey. Scand J Gastroenterol 2008; 43: 821–30
- de Jonge PFJ, van Eijck BC, Geldof H, Bekkering FC, Essink-Bot M-L, Polinder S, et al. Capsule endoscopy for the detection of oesophageal mucosal disorders: a comparison of two different ingestion protocols. Scand J Gastroenterol 2008; 43: 870–7
- Martínek J, Beneš M, Hucl T, Drastich P, Štirand P, Špičák J. Nonerosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities. Scand J Gastroenterol 2008; 43: 794–800
- Koivisto TT, Voutilainen ME, Färkkilä MA. Symptoms, endoscopy findings and histology predicting symptomatic benefit of Helicobacter pylori eradication. Scand J Gastroenterol 2008; 43: 810–6
- Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, et al. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 2008; 43: 831–41
- Park SY, Lee SK, Kim BC, Han J, Kim JH, Cheon JH, et al. The efficacy of chromoendoscopy with indigocarmine for the detection of ascending colon and cecum lesions. Scand J Gastroenterol 2008; 43: 878–85
- Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Scand J Gastroenterol 2008; 43: 849–56
- Rijnhart-de-Jong HG, Draaisma WA, Smout AJPM, Broeders IAMJ, Gooszen HG. The Visick score: A good measure for the overall effect of antireflux surgery?. Scand J Gastroenterol 2008; 43: 787–93
- Gelderblom HC, Zaaijer HL, Dijkgraaf MGW, van der Meer J, Weegink CJ, Jansen PLM, et al. Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy. Scand J Gastroenterol 2008; 43: 857–69
- Vilela EG, Ferrari MLA, Torres HOG, Pinto AG, Aguirre ACC, Martins FP, et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol 2008; 43: 842–8
- Kozakai T, Sakate M, Saida K. Regulation of endothelin-1 expression and function by nutrient stress in mouse colon epithelia. Scand J Gastroenterol 2008; 43: 886–94